Firebrick Pharma Ltd
Firebrick Pharma Limited engages in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand in Asia, North America, Europe, and internationally. It offers nasal spray PVP-I products for the treatment of common cold. The company was incorporated in 2012 and is based in Melbourne, Australia.
Firebrick Pharma Ltd (FRE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.759x
Based on the latest financial reports, Firebrick Pharma Ltd (FRE) has a cash flow conversion efficiency ratio of -0.759x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.18 Million) by net assets (AU$1.56 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Firebrick Pharma Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Firebrick Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Firebrick Pharma Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Firebrick Pharma Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Olympia Industries Bhd
KLSE:3018
|
-0.021x |
|
INTUITIVE SURGICAL - Dusseldorf Stock Exchang
DU:IUI1
|
0.045x |
|
Country Heights Holdings Bhd
KLSE:5738
|
-0.001x |
|
WANDA HOTEL DEVEL. CO.
F:CL1A
|
N/A |
|
EL. D. Mouzakis S.A
AT:MOYZK
|
0.002x |
|
Allied Electronics Corporation Ltd
JSE:AEL
|
0.163x |
|
SSR Inc
KQ:275630
|
0.006x |
|
J2 Metals Inc.
V:JTWO
|
N/A |
Annual Cash Flow Conversion Efficiency for Firebrick Pharma Ltd (2019–2025)
The table below shows the annual cash flow conversion efficiency of Firebrick Pharma Ltd from 2019 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$1.56 Million | AU$-1.78 Million | -1.143x | -3.12% |
| 2024-06-30 | AU$2.12 Million | AU$-2.34 Million | -1.109x | +52.54% |
| 2023-06-30 | AU$2.48 Million | AU$-5.78 Million | -2.336x | -360.20% |
| 2022-06-30 | AU$8.28 Million | AU$-4.20 Million | -0.508x | -202.88% |
| 2021-06-30 | AU$11.55 Million | AU$-1.94 Million | -0.168x | +93.35% |
| 2020-06-30 | AU$390.60K | AU$-985.01K | -2.522x | -155.58% |
| 2019-06-30 | AU$1.08 Million | AU$-1.06 Million | -0.987x | -- |